Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial cell membrane components refer to the complex lipid and protein structures that form the essential boundary of bacterial cells. This target includes the cytoplasmic membrane found in all bacteria and the additional outer membrane present in Gram-negative species, which is uniquely characterized by the presence of lipopolysaccharides (LPS) (Epand et al., 2016, Nature Reviews Microbiology). These membranes serve as a selective permeability barrier, maintaining the electrochemical gradient necessary for ATP synthesis and facilitating the transport of nutrients and waste (NCBI, 'Antibiotics that act on the cell membrane'). In clinical practice, these components are the primary targets for several potent antibiotics, including polymyxins and lipopeptides like daptomycin (Li et al., 2006, Lancet Infectious Diseases; Straus & Hancock, 2006, Biochimica et Biophysica Acta). These drugs typically act by disrupting the physical integrity of the lipid bilayer or inducing rapid depolarization, which results in the loss of cytoplasmic contents and immediate cessation of cellular processes. While highly effective against multi-drug resistant pathogens, targeting the bacterial membrane presents challenges due to potential toxicity in human cells, particularly in the kidneys and nervous system (Li et al., 2006). Understanding the specific lipid composition of these membranes is crucial for developing next-generation antimicrobials that minimize off-target effects while overcoming emerging resistance mechanisms.
Binding to lipopolysaccharides (LPS) in Gram-negative bacteria or acidic phospholipids like phosphatidylglycerol in Gram-positive bacteria, followed by membrane insertion, pore formation, and rapid depolarization of the transmembrane potential, leading to the leakage of essential intracellular ions and cell death (Li et al., 2006; Straus & Hancock, 2006).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cell membrane components.